Biomarkers of Electronic Nicotine Delivery Systems (ENDS) use

[1]  Matthew R. Holman,et al.  Harmful and Potentially Harmful Constituents in the Filler and Smoke of Tobacco-Containing Tobacco Products , 2022, ACS omega.

[2]  N. Benowitz,et al.  Minor Tobacco Alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New Analytical Methods , 2022, Frontiers in Chemistry.

[3]  Nikola Pluym,et al.  Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products. , 2022, Chemical research in toxicology.

[4]  A. Hyland,et al.  Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013–2015 , 2022, International journal of environmental research and public health.

[5]  P. Lorkiewicz,et al.  Electronic Cigarette Solvents, JUUL E-Liquids, and Biomarkers of Exposure: In Vivo Evidence for Acrolein and Glycidol in E-Cig-Derived Aerosols , 2022, Chemical research in toxicology.

[6]  Lijun Liu,et al.  The Emission of VOCs and CO from Heated Tobacco Products, Electronic Cigarettes, and Conventional Cigarettes, and Their Health Risk , 2021, Toxics.

[7]  B. Blount,et al.  Optimal Cutoff Concentration of Urinary Cyanoethyl Mercapturic Acid for Differentiating Cigarette Smokers from Nonsmokers. , 2021, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  D. Hatsukami,et al.  A randomized trial of nicotine vs. no-nicotine e-cigarettes among African American smokers: Changes in smoking and tobacco biomarkers. , 2021, Nicotine & Tobacco Research.

[9]  Nikola Pluym,et al.  1,2-Propylene Glycol: A Biomarker of Exposure Specific to e-Cigarette Consumption , 2021, Separations.

[10]  S. Shiffman,et al.  Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers , 2021, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[11]  K. Pinkerton,et al.  Impact of e-Liquid Composition, Coil Temperature, and Puff Topography on the Aerosol Chemistry of Electronic Cigarettes. , 2021, Chemical research in toxicology.

[12]  Sungroul Kim,et al.  Comparison of Nicotine Dependence and Biomarker Levels among Traditional Cigarette, Heat-Not-Burn Cigarette, and Liquid E-Cigarette Users: Results from the Think Study , 2021, International journal of environmental research and public health.

[13]  C. Bullen,et al.  Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial. , 2021, The Lancet. Respiratory medicine.

[14]  Michael T. Simonich,et al.  The chemistry and toxicology of vaping. , 2021, Pharmacology & therapeutics.

[15]  A. Hyland,et al.  Exposure to Nicotine and Toxicants Among Dual Users of Tobacco Cigarettes and E-Cigarettes: Population Assessment of Tobacco and Health (PATH) Study, 2013-2014. , 2021, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[16]  Emily A Eshraghian,et al.  A review of constituents identified in e-cigarette liquids and aerosols , 2021, Tobacco prevention & cessation.

[17]  T. Rosado,et al.  Recent Developments in the Determination of Biomarkers of Tobacco Smoke Exposure in Biological Specimens: A Review , 2021, International journal of environmental research and public health.

[18]  B. Blount,et al.  Characterization of Acrylonitrile Exposure in the United States based on Urinary N-Acetyl-S-(2-cyanoethyl)-L-cysteine (2CYEMA): NHANES 2011–2016 , 2020, Journal of Exposure Science & Environmental Epidemiology.

[19]  H. Digard,et al.  The Evolving E-cigarette: Comparative Chemical Analyses of E-cigarette Vapor and Cigarette Smoke , 2020, Frontiers in Toxicology.

[20]  Nicole L. Nollen,et al.  Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African American and Latinx Smokers , 2020, JAMA network open.

[21]  B. Xia,et al.  Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries , 2020, Toxics.

[22]  C. Kubwabo,et al.  A review of the analysis of biomarkers of exposure to tobacco and vaping products. , 2020, Analytical methods : advancing methods and applications.

[23]  Blair Coleman,et al.  Nicotine Exposure by Device Type among Adult Electronic Nicotine Delivery System Users in the Population Assessment of Tobacco and Health Study, 2015–2016 , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[24]  A. Hyland,et al.  Urinary Biomarkers of Exposure to Volatile Organic Compounds from the Population Assessment of Tobacco and Health Study Wave 1 (2013–2014) , 2020, International journal of environmental research and public health.

[25]  A. Hyland,et al.  Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014). , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[26]  A. Breland,et al.  Are Urine Propylene Glycol or Vegetable Glycerin Markers of E-cigarette Use or Abstinence? , 2020, Tobacco Regulatory Science.

[27]  L. Le Marchand,et al.  Urinary cyanoethyl mercapturic acid, a biomarker of the smoke toxicant acrylonitrile, clearly distinguishes smokers from non-smokers. , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[28]  L. Kośmider,et al.  Metal Concentration Assessment in the Urine of Cigarette Smokers Who Switched to Electronic Cigarettes: A Pilot Study , 2020, International journal of environmental research and public health.

[29]  C. Hewitt,et al.  The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial , 2019, Trials.

[30]  N. Benowitz,et al.  Twenty-four Hour Subjective and Pharmacological Effects of Ad Libitum Electronic and Combustible Cigarette Use among Dual Users. , 2019, Addiction.

[31]  N. Benowitz,et al.  Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[32]  M. Goniewicz,et al.  Are E-Cigarette Flavors Associated with Exposure to Nicotine and Toxicants? Findings from Wave 2 of the Population Assessment of Tobacco and Health (PATH) Study , 2019, International journal of environmental research and public health.

[33]  Megan E. Piper,et al.  Biochemical Verification of Tobacco Use and Abstinence: 2019 Update. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[34]  A. Hyland,et al.  Nicotine and Toxicant Exposure among Concurrent Users ("Co-users") of Tobacco and Cannabis. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[35]  B. Dautzenberg,et al.  Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol , 2019, BMJ Open.

[36]  M. Goniewicz,et al.  Self-Reported Use of Tobacco, E-cigarettes, and Marijuana Versus Urinary Biomarkers , 2019, Pediatrics.

[37]  M. Goniewicz,et al.  Are Some E-Cigarette Users "Blowing Smoke"?: Assessing the Accuracy of Self-Reported Smoking Abstinence in Exclusive E-Cigarette Users. , 2019, Nicotine & Tobacco Research.

[38]  P. Lorkiewicz,et al.  Characterization of Volatile Organic Compound (VOC) metabolites in Cigarette smokers, Electronic Nicotine Device Users, Dual Users and Non- users of tobacco. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[39]  A. Hyland,et al.  Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013–2014) , 2018, Environment international.

[40]  R. Niessner,et al.  Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients , 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[41]  P. Sinharoy,et al.  Environmental Aldehyde Sources and the Health Implications of Exposure. , 2019, Advances in experimental medicine and biology.

[42]  P. Lorkiewicz,et al.  Comparison of Urinary Biomarkers of Exposure in Humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[43]  A. Hyland,et al.  Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes , 2018, JAMA network open.

[44]  M. Goniewicz,et al.  Biomarkers of exposure among "dual users" of tobacco cigarettes and electronic cigarettes in Canada. , 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[45]  H. McRobbie,et al.  ‘Real‐world’ compensatory behaviour with low nicotine concentration e‐liquid: subjective effects and nicotine, acrolein and formaldehyde exposure , 2018, Addiction.

[46]  R. Jain.  Revised and extended serum cotinine cut-offs to classify smokers and non-smokers , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[47]  Nicole L. Nollen,et al.  Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[48]  P. Jatlow,et al.  Biomarkers of exposure to new and emerging tobacco delivery products. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[49]  Jennifer L. Pearson,et al.  Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013–2014 , 2017, Tobacco Control.

[50]  R. Strongin,et al.  Solvent Chemistry in the Electronic Cigarette Reaction Vessel , 2017, Scientific Reports.

[51]  R. West,et al.  Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users , 2017, Annals of Internal Medicine.

[52]  N. Benowitz,et al.  Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[53]  H. McRobbie,et al.  E-cigarette puffing patterns associated with high and low nicotine e-liquid strength: effects on toxicant and carcinogen exposure , 2016, BMC Public Health.

[54]  H. Destaillats,et al.  Emissions from Electronic Cigarettes: Key Parameters Affecting the Release of Harmful Chemicals. , 2016, Environmental science & technology.

[55]  G. O’Connell,et al.  Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers , 2016, Toxicology mechanisms and methods.

[56]  D. Graff,et al.  Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes , 2016, BMC Public Health.

[57]  Katie Myers Smith,et al.  Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein , 2015, Cancer Prevention Research.

[58]  W. Bailey,et al.  NIH electronic cigarette workshop: developing a research agenda. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[59]  C. B. Clark,et al.  How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[60]  Andrzej Sobczak,et al.  Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[61]  G. McMillin,et al.  Reference interval determination for anabasine: a biomarker of active tobacco use. , 2014, Journal of analytical toxicology.

[62]  William Mattes,et al.  Biomarkers of tobacco smoke exposure. , 2014, Advances in clinical chemistry.

[63]  N. Benowitz,et al.  Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke. , 2013, Chemical research in toxicology.

[64]  Andrzej Sobczak,et al.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes , 2013, Tobacco Control.

[65]  P. Murthy,et al.  Birth Order and Sibling Gender Ratio of a Clinical Sample Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications Chemical Components of Cannabis , 2022 .

[66]  Huaqin Pan,et al.  The PhenX Toolkit: Get the Most From Your Measures , 2011, American journal of epidemiology.

[67]  N. Benowitz,et al.  Elimination Kinetics of the Tobacco-Specific Biomarker and Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[68]  P. Boogaard.  Urinary biomarkers in the risk assessment of PAHs , 2008, Occupational and Environmental Medicine.

[69]  D. Hatsukami,et al.  Biomarkers to assess the utility of potential reduced exposure tobacco products. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[70]  S. Hall,et al.  Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[71]  S. Hecht,et al.  Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines. , 1994, Cancer research.